IV Keppra in the emergency department for prevention of early recurrent seizures

Trial Profile

IV Keppra in the emergency department for prevention of early recurrent seizures

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Aug 2016

At a glance

  • Drugs Fosphenytoin (Primary) ; Levetiracetam (Primary) ; Phenytoin (Primary)
  • Indications Tonic-clonic epilepsy
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Dec 2008 Actual patient number (158) added as reported by ClinicalTrials.gov.
    • 08 Dec 2008 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
    • 08 Dec 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top